494 related articles for article (PubMed ID: 17091471)
1. Eukaryotic initiation factor 4E variants alter the morphology, proliferation, and colony-formation properties of MDA-MB-435 cancer cells.
Goldson TM; Vielhauer G; Staub E; Miller S; Shim H; Hagedorn CH
Mol Carcinog; 2007 Jan; 46(1):71-84. PubMed ID: 17091471
[TBL] [Abstract][Full Text] [Related]
2. Tumor-specific RNAi targeting eIF4E suppresses tumor growth, induces apoptosis and enhances cisplatin cytotoxicity in human breast carcinoma cells.
Dong K; Wang R; Wang X; Lin F; Shen JJ; Gao P; Zhang HZ
Breast Cancer Res Treat; 2009 Feb; 113(3):443-56. PubMed ID: 18327707
[TBL] [Abstract][Full Text] [Related]
3. High affinity RNA for mammalian initiation factor 4E interferes with mRNA-cap binding and inhibits translation.
Mochizuki K; Oguro A; Ohtsu T; Sonenberg N; Nakamura Y
RNA; 2005 Jan; 11(1):77-89. PubMed ID: 15611299
[TBL] [Abstract][Full Text] [Related]
4. Translational upregulation of yes accompanies eIF4E-mediated oncogenic transformation.
Defatta RJ; De Benedetti A
Int J Oncol; 2003 Dec; 23(6):1709-13. PubMed ID: 14612945
[TBL] [Abstract][Full Text] [Related]
5. The effect of p-4E-BP1 and p-eIF4E on cell proliferation in a breast cancer model.
Pons B; Peg V; Vázquez-Sánchez MA; López-Vicente L; Argelaguet E; Coch L; Martínez A; Hernández-Losa J; Armengol G; Ramon Y Cajal S
Int J Oncol; 2011 Nov; 39(5):1337-45. PubMed ID: 21750861
[TBL] [Abstract][Full Text] [Related]
6. Antisense RNA to eIF4E suppresses oncogenic properties of a head and neck squamous cell carcinoma cell line.
DeFatta RJ; Nathan CO; De Benedetti A
Laryngoscope; 2000 Jun; 110(6):928-33. PubMed ID: 10852506
[TBL] [Abstract][Full Text] [Related]
7. eIF4E, the mRNA cap-binding protein: from basic discovery to translational research.
Sonenberg N
Biochem Cell Biol; 2008 Apr; 86(2):178-83. PubMed ID: 18443631
[TBL] [Abstract][Full Text] [Related]
8. Increase in cap- and IRES-dependent protein synthesis by overproduction of translation initiation factor eIF4G.
Hayashi S; Nishimura K; Fukuchi-Shimogori T; Kashiwagi K; Igarashi K
Biochem Biophys Res Commun; 2000 Oct; 277(1):117-23. PubMed ID: 11027650
[TBL] [Abstract][Full Text] [Related]
9. Selective killing of cancer cells based on translational control of a suicide gene.
DeFatta RJ; Li Y; De Benedetti A
Cancer Gene Ther; 2002 Jul; 9(7):573-8. PubMed ID: 12082457
[TBL] [Abstract][Full Text] [Related]
10. Expression levels of eIF4E, VEGF, and cyclin D1, and correlation of eIF4E with VEGF and cyclin D1 in multi-tumor tissue microarray.
Yang SX; Hewitt SM; Steinberg SM; Liewehr DJ; Swain SM
Oncol Rep; 2007 Feb; 17(2):281-7. PubMed ID: 17203162
[TBL] [Abstract][Full Text] [Related]
11. Eukaryotic initiation factor-4E in superficial and muscle invasive bladder cancer and its correlation with vascular endothelial growth factor expression and tumour progression.
Crew JP; Fuggle S; Bicknell R; Cranston DW; de Benedetti A; Harris AL
Br J Cancer; 2000 Jan; 82(1):161-6. PubMed ID: 10638984
[TBL] [Abstract][Full Text] [Related]
12. Structures of the human eIF4E homologous protein, h4EHP, in its m7GTP-bound and unliganded forms.
Rosettani P; Knapp S; Vismara MG; Rusconi L; Cameron AD
J Mol Biol; 2007 May; 368(3):691-705. PubMed ID: 17368478
[TBL] [Abstract][Full Text] [Related]
13. eIF4E--from translation to transformation.
Mamane Y; Petroulakis E; Rong L; Yoshida K; Ler LW; Sonenberg N
Oncogene; 2004 Apr; 23(18):3172-9. PubMed ID: 15094766
[TBL] [Abstract][Full Text] [Related]
14. Interaction of three Caenorhabditis elegans isoforms of translation initiation factor eIF4E with mono- and trimethylated mRNA 5' cap analogues.
Stachelska A; Wieczorek Z; Ruszczyńska K; Stolarski R; Pietrzak M; Lamphear BJ; Rhoads RE; Darzynkiewicz E; Jankowska-Anyszka M
Acta Biochim Pol; 2002; 49(3):671-82. PubMed ID: 12422237
[TBL] [Abstract][Full Text] [Related]
15. Global alterations in mRNA polysomal recruitment in a cell model of colorectal cancer progression to metastasis.
Provenzani A; Fronza R; Loreni F; Pascale A; Amadio M; Quattrone A
Carcinogenesis; 2006 Jul; 27(7):1323-33. PubMed ID: 16531451
[TBL] [Abstract][Full Text] [Related]
16. Proto oncogene/eukaryotic translation initiation factor (eIF) 4E attenuates mevalonate-mediated regulation of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase synthesis.
Buechler RD; Peffley DM
Mol Carcinog; 2004 Sep; 41(1):39-53. PubMed ID: 15352124
[TBL] [Abstract][Full Text] [Related]
17. Regulation of cap-dependent translation initiation in the early stage porcine parthenotes.
Susor A; Jelínková L; Karabínová P; Torner H; Tomek W; Kovárová H; Kubelka M
Mol Reprod Dev; 2008 Dec; 75(12):1716-25. PubMed ID: 18386287
[TBL] [Abstract][Full Text] [Related]
18. Phosphorylation of the eukaryotic translation initiation factor eIF4E contributes to its transformation and mRNA transport activities.
Topisirovic I; Ruiz-Gutierrez M; Borden KL
Cancer Res; 2004 Dec; 64(23):8639-42. PubMed ID: 15574771
[TBL] [Abstract][Full Text] [Related]
19. The expression and phosphorylation of eukaryotic initiation factor 4E are increased in lesional psoriatic skin.
Kjellerup RB; Iversen L; Kragballe K; Johansen C
Br J Dermatol; 2009 Nov; 161(5):1059-66. PubMed ID: 19663871
[TBL] [Abstract][Full Text] [Related]
20. Regulation of cap-dependent translation by eIF4E inhibitory proteins.
Richter JD; Sonenberg N
Nature; 2005 Feb; 433(7025):477-80. PubMed ID: 15690031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
